Caribou Biosciences, Inc.

NASDAQ:CRBU

0.9855 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -149.105-102.07-99.421-66.923-34.308-23.431
Depreciation & Amortization 3.9273.5251.6220.9840.90.751
Deferred Income Tax -0.010-0.095-1.5220.8030
Stock Based Compensation 16.70613.7511.7163.4491.0021.234
Change In Working Capital -5.114-7.318-4.20429.0670.177-8.267
Accounts Receivables 0.6080.8050.951-1.003-0.1460.617
Inventory 000-2.21.355-2.224
Accounts Payables -0.3541.819-2.7211.1390.0431.176
Other Working Capital -5.368-9.942-2.43431.131-1.075-7.836
Other Non Cash Items -4.604-1.178-0.5842.426-1.789-2.293
Operating Cash Flow -138.2-93.291-90.966-32.519-33.215-32.006
Investing Activities:
Investments In Property Plant And Equipment -4.88-11.613-7.054-3.121-1.315-0.884
Acquisitions Net 000.600.010
Purchases Of Investments -309.119-394.758-339.063-173.276-0.010
Sales Maturities Of Investments 397.492338.188252.86807.66828.117
Other Investing Activites 3.1140-0.6-10.0128.117
Investing Cash Flow 86.607-68.183-93.249-176.3976.36327.233
Financing Activities:
Debt Repayment 0001.0311.465-0.045
Common Stock Issued 15.192152.722.133321.020.270.217
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 1.5321.5782.133111.3780.270.217
Financing Cash Flow 16.724154.2982.133433.4291.7350.172
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -34.869-7.176-182.082224.513-25.117-4.601
Cash At End Of Period 16.33951.20858.384240.46615.95341.07